<DOC>
	<DOCNO>NCT01746680</DOCNO>
	<brief_summary>The aim study assess efficacy safety tacrolimus patient active rheumatoid arthritis ( RA ) . EULAR ( European League Against Rheumatism ) response week 24 compare baseline evaluate assess efficacy Tacrolimus .</brief_summary>
	<brief_title>Efficacy Safety Study Tacrobell Treat Rheumatoid Arthritis</brief_title>
	<detailed_description>A Phase IV , Open label , Multi-Center Trial Assess Efficacy Safety Tacrolimus ( Tacrobell® ) patient active rheumatoid arthritis ( RA ) .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>Male female age ≥20years Signed date informed consent document indicate patient Women childbearing potential must negative serum urine pregnancy test screen visit . Except case surgically sterile amenorrhea one year . Female patient must agree use adequate contraception measure period therapy continue 4 week . RA meet follow criterion ; RA occur ≥ 3months less 15 year diagnose base 1987 ACR classification criterion rheumatoid arthritis ; Active RA patient MTX among insufficiency response DMARDs define DAS28 &gt; 3.2 active RA patient . Insufficiency response define despite MTX therapy &gt; 12 week , RA activity≥ moderate confirmable 12 week , sequence take MTX &gt; 7.5mg/week 6 week ; ESR≥28mm/h CRP≥1.0mg/dl ; Tender Joint Counts must 6 Swollen Joint Counts must 3 Inflammatory joint disease , Systematic inflammatory disease Prosthesis event infect . Medical history chronic infection , moderate infection possibly life threaten sign symptom serious infection . Patients receive treatment live vaccine baseline within 8 week . HBsAg positive hepatitis C virus positive patient . Patients history malignancy . ( But , carcinoma situ uterine cervix basal cell carcinoma treat allow within 5years ) Patients cardiovascular disease associate disease control . uncontrollable blood sugar ( HbA1C ≥8 % ) require insulin . Patients history operation index knee joint could influence result need surgery determine investigator . At screening , patient laboratory result define ; white blood cell ( WBC ) &lt; 3,500/mm3 , Absolute Neutrophil Count ( ANC ) &lt; 1,500/mm3 , Hemoglobin &lt; 8.5g/dl , Platelet count ( PLT ) &lt; 100,000/mm3 , Serum creatinine &gt; 1.5*upper limit normal 2mg/dl , Total bilirubin &gt; 2*upper limit normal , aspartate aminotransferase ( AST ) &gt; 2*upper limit normal , alanine aminotransferase ( ALT ) &gt; 2*upper limit normal , alkaline phosphatase ( ALP ) &gt; 2*upper limit normal Patients clinical trial experimental treatment past 8weeks An impossible one participate clinical trial investigator 's decision</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>rheumatoid arthritis</keyword>
	<keyword>RA</keyword>
	<keyword>tacrolimus</keyword>
	<keyword>Disease Activity Score 28</keyword>
	<keyword>EULAR</keyword>
</DOC>